The Ben Towne Center's labs are at the forefront of developing therapies that use the immune system to destroy cancer, without the devastating side effects of chemotherapy or radiation.
Led by Dr. Heather Gustafson, EDIT Labs develops novel technology platforms that target and alter macrophage phenotypes.
The Kalia Lab is enabling progress toward immunotherapies that can be applied to any type of cancer.
The Lawlor Lab research focuses on Ewing sarcoma, an aggressive bone and soft tissue tumor for which new cures are needed.
The Orentas Lab investigates how the immune system and CAR T-cell immunotherapies can be leveraged to fight childhood childhood cancers like rhabdomyosarcoma, osteosarcoma, Ewing’s sarcoma and neuroblastoma.
The Sarkar Lab is finding ways to help the immune system remember cancer and attack it if it relapses – whether that’s months or decades after a child goes into remission.